July 10, 2014

Ateb on Thursday announced it has reached an agreement to license Walgreens' entire portfolio of prescription alignment patents in an effort to continue to improve overall health care, demonstrate the value of medication synchronization and increase patient adherence rates.

July 10, 2014

As lifetime earnings for pharmaceuticals decrease, commercialization expenses increase and payers tighten their belts on reimbursement, life science companies will be faced with shrinking margins over the next few years. In order to maintain basic operating margin levels and continue investing in research and development at current levels, life science manufacturers will be forced to reduce costs by more than $35 billion by 2017, according to results from a new survey of 70 life science organizations from the IMS Institute for Healthcare Informatics.

July 10, 2014

The Food and Drug Administration in late June issued a warning letter to Zarbee's for making therapeutic claims regarding a dietary supplement product.

July 10, 2014

The Food and Drug Administration on Wednesday shut down a company for noncompliance of the dietary supplement current good manufacturing practice requirements. 

July 10, 2014

A survey co-released by the Generic Pharmaceutical Association and the National Coalition on Healthcare reveals that 8-in-10 healthcare providers have serious concerns about a proposed Food and Drug Administration rule on generic drug labeling.

July 10, 2014

The Office of National Drug Control Policy released the 2014 National Drug Control Strategy, the Obama Administration’s primary blueprint for drug policy in the United States.

July 10, 2014

VoicePort on Thursday announced a patent licensing agreement with Walgreens that covers 11 U.S. patents and patent applications owned by Walgreens in the field of prescription alignment.

July 8, 2014

Canada’s pharmacy retailer the Jean Coutu Group is optimistic about the expanded role of pharmacists in Quebec under Bill 41.

July 8, 2014

Attendees will have the opportunity to learn directly from the FDA about the implications of the Drug Supply Chain Security Act of 2014.

July 8, 2014

NeuroMetrix on Tuesday announced that its wearable technology for treatment of chronic pain received 510(k) clearance from the Food and Drug Administration for over-the-counter use.

July 7, 2014

Cardinal Health recently introduced a legislative toolkit that makes it easy for community pharmacists to share their views about policies affecting the pharmacy industry.

July 7, 2014

Cardinal Health on Monday announced that nine pharmacy schools across the country will collectively receive $2 million in funding through the Cardinal Health Pharmacy Scholarship Program in 2014.

July 7, 2014

The theme for this year’s Cardinal Health RBC 2014 is “Leading Change.” For community pharmacists, that means playing a more active role in patient care. And Cardinal Health has a suite of services to help community pharmacists take the next step in making a difference in their patients’ lives — the Cardinal Health Adherence Suite.

July 7, 2014

CVS/pharmacy has replaced certain single-ingredient pseudoephedrine products with the tamper-resistant PSE product, Zephrex-D, in all of its West Virginia stores, as well as stores in nearby states that are located within 15 miles of West Virginia's border, including Kentucky, Maryland, Ohio, Pennsylvania and Virginia.

July 7, 2014

Drug Store News recently sat down with Alcon’s Mike McAvoy, head of OTC sales, to discuss opportunities in eye-care.

July 7, 2014

According to a report from the American Academy of Family Physicians, the Advisory Committee on Immunization Practices for the Centers for Disease Control and Prevention voted unanimously to recommend that healthy children between the ages of 2 years and 8 years be inoculated with a live attenuated influenza vaccine like FluMist, as opposed to the traditional flu shot. 

July 7, 2014

Sandoz announced the launch of valsartan tablets, an authorized generic version of Diovan tablets which is used for the treatment of high blood pressure.

July 3, 2014

The Food and Drug Administration on Tuesday made available a draft of its strategic priorities over the next four years for public comment.

July 3, 2014

Impax Labs on Wednesday announced that it has acquired from Actavis two generic products for cash consideration. Financial terms of the agreement were not disclosed.

July 3, 2014

Rite Aid realized a 3.9% same-store sales increase for the four weeks ended June 28, the company reported Thursday. 

July 3, 2014

Walgreens on Thursday reported June sales of $6.3 billion, an increase of 8.9% as compared to the same month in fiscal 2013.

 

July 2, 2014

Health care providers wrote 259 million prescriptions for opioid painkillers in 2012 — many more in some states than in others — according to a Vital Signs report released Tuesday by the Centers for Disease Control and Prevention that highlights the danger of overdose.

July 2, 2014

On June 25, the U.S. Department of Justice, at the request of the Food and Drug Administration, filed a complaint for permanent injunction in the U.S. District Court for the Central District of California against Laclede of Rancho Dominguez, Calif., and its president, Michael Pellico.

July 2, 2014

The Food and Drug Administration on Tuesday issued several policy documents regarding compounding as part of the agency’s continuing effort to implement the compounding provisions of the Drug Quality and Security Act enacted in November 2013.